Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

NCT01653743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Anovulation
Oligo-ovulation
Hypothalamic-pituitary Dysfunction
Polycystic Ovarian Syndrome

Interventions

DRUG: MSJ-0011
DRUG: urinary hCG (u-hCG)
DRUG: Follitropin alpha

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]